Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

15

Number of overlapping holdings

33.3%

% of IDNA's 49 holdings also in CANC

31.9%

% of CANC's 47 holdings also in IDNA

Overlap by Weight
Sector Drift (IDNA minus CANC)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in IDNA
Weight
in CANC
Overlap
GILEAD SCIENCES INC 5.7% 5.4% 5.4%
REVOLUTION MEDICINES, INC. 5.7% 4.6% 4.6%
INCYTE CORP 5.0% 4.2% 4.2%
EXELIXIS INC 6.6% 3.0% 3.0%
REGENERON PHARMACEUTICALS 3.0% 5.4% 3.0%

Position Highlights (Non-Overlapping Exposures)
IDNA Overweight Relative to CANC
BEIGENE, LTD. 5.4%
SAREPTA THERAPEUTICS INC 4.3%
ROCHE HOLDING LTD 4.3%
TAKEDA PHARMACEUTICAL CO LTD 4.0%
SANOFI-AVENTIS 4.0%
BIONTECH SE SPONSORED ADR 3.7%
EXELIXIS INC 3.6%
GSK PLC 3.2%
GENMAB A/S 3.1%
TWIST BIOSCIENCE CORP. 3.0%
IDNA Underweight Relative to CANC
ASTRAZENECA PLC -5.2%
ARGENX SE ADR -4.3%
ILLUMINA INC -3.8%
CHUGAI PHARMACEUTICAL CO LTD -3.3%
DAIICHI SANKYO CO LTD -3.1%
BLUEPRINT MEDICINES CORP. -2.9%
AGIOS PHARMACEUTICALS INC -2.9%
BEIGENE LTD. SPONSORED ADR -2.5%
REGENERON PHARMACEUTICALS -2.4%
GUARDANT HEALTH, INC. -2.4%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY